Library - Page 6 - Scientific articles and publications about the drug Mexidol®.

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The effect of antioxidant therapy on some pathogenetic factors of primary open -angle glaucoma

Authors:
T.N. Malishevskaya ¹ , Yu.E. Filippova ²

¹ FSBI "National Medical Research Center of Eye Diseases named after Helmholtz »Ministry of Health of Russia, Moscow, Russia;
² GAUZ “Regional Ophthalmological Dispensary”, Tyumen, Russia

Experience in the use of metabolic drugs in interventional cardiology

Authors:

A.A. Spassky, A.A. Mikhailov

Place of publication:
Cardionei, 2016

The possibilities and results of the use of antioxidant therapy in ophthalmological practice

Authors:
A.B. Movsisyan ^1.2 , J.G. Oganezova ^2.3 , E.A. Egorov ²

¹ GBUZ “Hospital for Wars of Wars No. 2 DZM”, Moscow, Russia;
² FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
³ FGBNU "Medical and Genetical Scientific Center named after Acad. N.P. Bochkova ", Moscow, Russia

The use of Mexidol in the treatment of primary open -angle glaucoma

Authors:
I.A. Loskutov, O.M. Andryukhina, A.A. Kovrizhkina

Moscow Regional Research Clinical Institute. M.F. Vladimir

The experience of neuroprotective therapy of primary open -angle glaucoma based on the use of various forms of Mexidol

Authors:
E.S. Leonova ^1.2 , S.V. Polyakov ^1.2 , M.A. Pozdnyakova ² , E.P. Yarygina ³ , S.O. Semisinov ²

¹ NUZ "Road Clinical Hospital at the Gorky station OJSC" Russian Railways ", the interdorrutal center of ophthalmology
² GBOU VPO" Nizhny Novgorod State Medical Academy "
³ GBUZ but" City Hospital No. 35 ", City Glacks Center

The experience of neuroprotective therapy of primary open -angle glaucoma based on the use of various forms of Mexidol

Authors:

E.S. Leonova1, 2, S.V. Polyakov1, 2, M.A. Pozdnyakova2, E.P. Yarygin3, S.O. Semisov2

1 nose "Road Clinical Hospital at the Gorky station OJSC" Russian Railways ", the interdorrutal center of ophthalmology, 18 Lenin Ave., Nizhny Novgorod, Russian Federation, 603140;

2GBOU VPO Nizhny Novgorod State Medical Academy, pl. Minina and Pozharsky, 10/1, Nizhny Novgorod, Russian Federation, 603950;

3GBUZ but "City Hospital No. 35", City Glack Center, ul. Osharskaya, 15, Nizhny Novgorod, Russian Federation, 603005

Place of publication:

Bulletin of ophthalmology 6, 2015

Assessment of Mexidol's effectiveness in the complex treatment of glaucomone neuropathy

Authors:
A.N. Bolatbekova, D.E. Kopbaeva, A.I. ARINOVA, B.S. Abrakhmanova

LLP "Center for Microsurgery of the Eye", Karaganda
KGP "Regional Clinical Hospital", Karaganda,
Karaganda State Medical University, Karaganda

Our experience in the use of Mexidol in the complex treatment of patients with primary open -angle glaucoma

Authors:
E.A. Afonina, M.A. Levko, L.V. Chekurova, T.I. Kosacheva

SZGMU them. I.I. Mechnikov, St. Petersburg

Antioxidant drug in neuroprotective therapy for glaucoma

Authors:
E.A. Egorov ¹ , A.A. Gvetadze ¹ , N.G. Davydova ²

¹ rnim them. N.I. Pirogov;
² FSBI "Moscow Research Institute of Eye Diseases. Helmholtz »Ministry of Health of the Russian Federation

The effectiveness of the use of 3-oxypyridine and amber acid derivatives in the complex treatment of primary open-angle glaucoma

Authors:
I.A. Volchersky ¹ , E.V. Tour ¹ , O.V. Solyannikova ¹ , V.S. Rykun ¹ , M.S. Sumin ² , V.N. Dmitrienko ² , E.V. Berdnikova ¹

¹ Department of Pharmacology (Head
^- Prof. Dmitrienko) GMLPUZ "Chelyabinsk Regional Clinical Hospital", Medgorodok

The influence of a water -soluble antioxidant drug (Mexidol) on the sensitivity of the optic nerve and blood flow velocity in the arteries of the eyeball and orbit in patients with the primary open -angle glaucoma

Authors:

I.A. Volchersky ¹ , E.V. Tour ¹ , O.V. Solyannikova ¹ , V.S. Rykun ¹ , E.V. Berdnikova ¹ , M.S. Sumin ² , V.N. Dmitrienko ²

¹ GBOU VPO "Chelyabinsk State Medical Academy" of the Ministry of Health and Social Development of Russia;
² GMLPUZ "Chelyabinsk Regional Clinical Hospital"

Mexidol in the complex treatment of glaucoma

Author:
E.A. Egorov, N.G. Davydova, I.A. Romanenko, N.D. Novikova

RNIMU named after N.I. Pirogov, GB of GB named after Helmholtz, Moscow

Mexidol in the complex therapy of stable angina pectoris

Authors:
G.I. Nechaeva ¹ , S.D. Kurochkina ² , A.D. Trotsenko ³ , E.Yu. Bulakhova ²

¹ Omsk State Medical Academy
² Buzoo City Clinical Hospital No. 4
³ Buzoo Medical Center of the Ministry of Health of the Omsk Region

International multicenteric randomized double-tied placebo-controlled study of evaluating the effectiveness and safety of sequential therapy of patients with chronic brain ischemia drugs Mexidol® and Mexidol® Forte 250 (study of memo): Subanalysis results in patients with arterial hypertension

V.V. Zakharov ¹ , O.D. Ostroumova ^1.2 , A.I. Kochetkov ² , M.V. Klepikov ² , A.I. Fedin ³

¹ FGAOU VO "First Moscow State Medical University named after THEM. Sechenov »Ministry of Health of Russia (Sechenov University);
² FSBEI of DPO “Russian Medical Academy of Continuing Professional Education” of the Ministry of Health of Russia, Moscow;
³ FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow

Place of publication:
therapy No. 1 (63) 2023

To the question of the evidence base of neuroprotective therapy: Focus on ethylmethylhydroxypyridine succinate

Authors:
A.I. Kochetkov, N.A. Shatalova, M.V. Klepikova, T.V. Filippova, O.D. Ostroumova
FSBEI DPO “Russian Medical Academy of Continuing Professional Education” of the Ministry of Health of Russia, Moscow

The effectiveness of Mexidol in patients of different age groups with chronic brain ischemia with cognitive disorders (the results of subanalysis of the international multicenter randomized double blind placebo-controlled study of memes)

Zakharov V.V. 1*, Tkacheva O.N. 2*, 3*, Mkhitaryan E.A. 2*, 3*, Fedin A.I. 2*

1* FGAOU VO "First Moscow State Medical University named after THEM. Sechenov »Ministry of Health of Russia
(Sechenov University), Moscow, Russia;
2* FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia,
Moscow, Russia;
3* Russian Gerontological Scientific and Clinical Center of the FGAOU in the Russian National Research
Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Place of publication:

Journal of neurology and psychiatry named after S.S. Korsakova
2022, vol. 122, No. 11, issue. 2, p. 73–80

« 1 … 4 5 6 7 8 … 14 »